diminazene aceturate has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaikwad, AB; Malek, V; Sharma, N | 1 |
1 other study(ies) available for diminazene aceturate and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Simultaneous inhibition of neprilysin and activation of ACE2 prevented diabetic cardiomyopathy.
Topics: Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Diminazene; Drug Therapy, Combination; Enzyme Activation; Male; Neprilysin; Peptidyl-Dipeptidase A; Rats, Wistar; Streptozocin; Thiorphan | 2019 |